United States News All stories

SAIC (NASDAQ:SAIC) reported fiscal second quarter 2027 revenue of $1.88 billion, up about 6% year over year, including 5.3% organic growth and approximately $20 million from the SilverEdge acquisition.

Pulsenmore (NASDAQ:PLSM) reported first half 2026 revenue of NIS 6.1 million, approximately $2 million, up 53% year over year, with gross profit also increasing 53% to NIS 2.2 million.

BioLineRx (NASDAQ:BLRX) reported second quarter 2026 results with royalty revenue of $0.3 million and a net loss of $4.3 million, compared with a net loss of $3.9 million in the prior-year period.

SLB (NYSE:SLB) signed an agreement to acquire Kelvion, a provider of thermal management and heat exchange technologies, for approximately $3.4 billion in cash to expand its data center infrastructure business.

Lilly (NYSE:LLY) signed a definitive agreement to acquire Merida Biosciences for up to $2.875 billion in cash, adding precision biologics programs targeting autoimmune and allergic diseases.

Aon (NYSE:AON) signed a definitive agreement to acquire USI from KKR and other shareholders for $17 billion, expanding its U.S. insurance brokerage operations.

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported second interim overall survival results from the Phase 3 HERIZON-GEA-01 trial showing Ziihera (zanidatamab-hrii) plus chemotherapy improved overall survival compared with trastuzumab plus chemotherapy in first-line HER2-positive gastroesophageal adenocarcinoma.

GameStop (NYSE:GME) reported preliminary second quarter 2026 results showing expected net income of $290 million to $310 million, compared with $168.6 million in the prior-year period.

BeOne Medicines (NASDAQ:ONC) reported Phase 3 HERIZON-GEA-01 trial results showing ZIIHERA (zanidatamab) plus chemotherapy produced a statistically significant improvement in overall survival compared with trastuzumab plus chemotherapy in first-line treatment of HER2-positive gastroesophageal adenocarcinoma.

IDEAYA Biosciences (NASDAQ:IDYA) reported that an FDA Type C meeting provided guidance for the planned global randomized Phase 3 trial of IDE849, a DLL3-targeting TOP1 antibody-drug conjugate for extensive stage small cell lung cancer.

So-Young (NASDAQ:SY) reported second quarter 2026 revenue of RMB505.2 million, up 33.4% year over year, driven mainly by growth in its branded aesthetic center business.

Nissan and Honda (NYSE:HMC) agreed to jointly develop vehicle computer parts and software for models planned to enter the market in fiscal 2029, with the companies sharing core electronic control units and software.

Alvotech (NASDAQ:ALVO) announced that the U.S. Food and Drug Administration accepted its Biologics License Application for AVT80, a proposed interchangeable biosimilar to Entyvio (vedolizumab) in prefilled syringe and autoinjector formats.

Brent crude futures rose 2% to $89.87 per barrel and U.S. West Texas Intermediate crude increased 1.74% to $84.85 after U.S. strikes on Iran’s Larak Island intensified concerns about energy flows through the Strait of Hormuz.

BioMarin (NASDAQ:BMRN) entered into binding global settlement terms with Ascendis Pharma A/S to resolve patent disputes involving Yuviwel, including a U.S. International Trade Commission investigation and litigation in multiple countries.

Amgen (NASDAQ:AMGN) reported Phase 3 VESALIUS-CV trial results showing Repatha reduced the risk of death by 20% among more than 12,000 high-risk adults without previous heart attack or stroke over a median 4.6-year follow-up.

LexinFintech Holdings (NASDAQ:LX) reported second quarter 2026 operating revenue of RMB3,187 million, down 11.2% year over year, while net income attributable to ordinary shareholders fell 80.2% to RMB101 million.

• SpaceX announced plans to launch Nvidia-powered AI satellite systems in Q4 2027, advancing its previous target for initial orbital data center deployments.
• The project combines SpaceX launch infrastructure with Nvidia Vera Rubin computing systems designed for AI workloads in orbit.
• The broader AI infrastructure market is expanding as semiconductor firms, cloud providers, and data center operators invest in higher computing capacity.

• DICK’S Sporting Goods (NYSE:DKS) reported Q2 2026 sales of $5.59 billion, up 53.2% year over year, after incorporating the Foot Locker acquisition into results.
• The company’s operating margin declined to 7.9% from 12.4%, while GAAP EPS fell to $3.50 as Foot Locker reported weaker performance and pressured profitability.
• The broader athletic retail sector faces pressure from changing footwear demand, inventory levels, and companies’ strategies to adjust product mixes and margins. 

Better Home & Finance Holding Company (NASDAQ:BETR) urged shareholders to reject former CEO Vishal Garg’s consent solicitation campaign, which seeks to remove five board members and install replacement directors.

Amarin (NASDAQ:AMRN) reported new post hoc REDUCE-IT Legacy analysis data showing that patients with high adherence to icosapent ethyl experienced an approximately 29%–30% relative reduction in the primary cardiovascular endpoint compared with placebo.

SuperX AI Technology (NASDAQ:SUPX) announced that subsidiary SuperX Microinference signed a long-term equipment and services supply agreement with Australian compute provider Ezisight for 128 B300 AI server clusters.

Best Buy (NYSE:BBY) announced that its Board of Directors authorized a regular quarterly cash dividend of $0.96 per common share, with payment scheduled for October 8, 2026.

Chagee Holdings (NASDAQ:CHA) reported second-quarter 2026 net revenue of RMB3,414.6 million (US$503.3 million), up 2.5% year over year from RMB3,331.9 million.